Cerebellar grey matter deficits in first-episode schizophrenia mapped using cortical pattern matching

NeuroImage
Paul E RasserPaul M Thompson

Abstract

Cerebellar dysfunction has been proposed to lead to "cognitive dysmetria" in schizophrenia via the cortico-cerebellar-thalamic-cortical circuit, contributing to a range of cognitive and clinical symptoms of the disorder. Here we investigated total cerebellar grey and white matter volumes and cerebellar regional grey matter abnormalities in 13 remitted first-episode schizophrenia patients with less than 2 years' duration of illness. Patient data were compared to 13 pair-wise age, gender, and handedness-matched healthy volunteers using cortical pattern averaging on high-resolution magnetic resonance images. Total cerebellar volume and total grey matter volumes in first-episode schizophrenia patients did not differ from healthy control subjects, but total cerebellar white matter was increased and total grey to white matter ratios were reduced in patients. Four clusters of cerebellar grey matter reduction were identified: (i) in superior vermis; (ii) in the left lobuli VI; (iii) in right-inferior lobule IX, extending into left lobule IX; and (iv) bilaterally in the areas of lobuli III, peduncle and left flocculus. Grey matter deficits were particularly prominent in right lobuli III and IX, left flocculus and bilateral pedunculi. Th...Continue Reading

References

Oct 1, 1979·The Journal of Nervous and Mental Disease·R G HeathD Shraberg
May 1, 1982·The American Journal of Psychiatry·S LippmannS Alrajeh
Mar 1, 1980·The American Journal of Psychiatry·D R WeinbergerR J Wyatt
Jan 1, 1995·Schizophrenia Bulletin·P Martin, M Albers
Mar 1, 1993·Biological Psychiatry·A RossiM Casacchia
Apr 8, 1998·Journal of Computer Assisted Tomography·C J HolmesA C Evans
Jun 9, 1998·IEEE Transactions on Medical Imaging·J G SledA C Evans
Jun 9, 1998·IEEE Transactions on Medical Imaging·M S Atkins, B T Mackiewich
Oct 3, 1998·Cerebral Cortex·P M ThompsonA W Toga
Jun 1, 2001·The American Journal of Psychiatry·R T LoeberD A Yurgelun-Todd
Sep 8, 2001·Philosophical Transactions of the Royal Society of London. Series B, Biological Sciences·J MazziottaB Mazoyer
Apr 17, 2002·Schizophrenia Research·Gaku OkugawaIngrid Agartz
Dec 31, 2002·The American Journal of Psychiatry·Audrey KellerJudith L Rapoport
Aug 29, 2003·The American Journal of Psychiatry·Gaku OkugawaIngrid Agartz
Aug 18, 2004·Psychiatry Research·Christian C JoyalHannu J Aronen
Nov 4, 2004·Biological Psychiatry·Manjinder S BagaryMaria A Ron
Dec 7, 2005·The American Journal of Psychiatry·Robyn HoneaClare E Mackay
Apr 22, 2006·Journal of Psychiatric Research·Kwang-Hyuk LeePeter W R Woodruff
Apr 9, 2008·Biological Psychiatry·Nancy C Andreasen, Ronald Pierson
Sep 16, 2008·Schizophrenia Research·Stefan J BorgwardtAnita Riecher-Rössler
Sep 18, 2008·Neuroreport·Nuria SegarraCarme Junque
Oct 7, 2008·Brain and Cognition·Uwe J Ilg, Peter Thier
Oct 10, 2008·Cerebral Cortex·Paul M ThompsonUNKNOWN HGDH Study Group
Oct 11, 2008·Brain and Cognition·Gillian A O'Driscoll, Brandy L Callahan
Nov 8, 2008·Annals of the New York Academy of Sciences·Jeremy D SchmahmannChristopher M Filley
Nov 21, 2008·Psychiatry Research·Ganesan VenkatasubramanianMatcheri S Keshavan
Dec 24, 2008·Annals of General Psychiatry·Yujiro YoshiharaNori Takei
Apr 9, 2009·Schizophrenia Research·Amanda R BolbeckerWilliam P Hetrick
Aug 12, 2009·Brain and Language·Catherine J Stoodley, Jeremy D Schmahmann

❮ Previous
Next ❯

Citations

Dec 2, 2011·Brain Structure & Function·Simone KühnJürgen Gallinat
Sep 4, 2013·Molecular Psychiatry·J EllegoodJ A Gogos
Aug 8, 2012·PloS One·Jerillyn S KentWilliam P Hetrick
May 23, 2014·PloS One·Amanda R BolbeckerWilliam P Hetrick
Jun 5, 2014·Schizophrenia Bulletin·Deanna M Barch
May 29, 2012·Psychiatry Research·Hernàn PicardCécile Beauvillain
Jan 7, 2016·Frontiers in Psychiatry·Jerillyn S KentWilliam P Hetrick
May 17, 2011·Biological Psychiatry·Owen R PhillipsKatherine L Narr
Feb 27, 2015·The International Journal of Neuropsychopharmacology·Valerie M AndersonBruce R Russell
May 12, 2011·The International Journal of Neuropsychopharmacology·Martin CohenUlrich Schall
Oct 28, 2016·Journal of Child Psychology and Psychiatry, and Allied Disciplines·Petya D RadoevaWendy R Kates
Dec 22, 2017·Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova·E B TereshkinaG Sh Burbaeva
Jan 19, 2019·Science·Ilaria CartaKamran Khodakhah
Apr 7, 2019·European Archives of Psychiatry and Clinical Neuroscience·Mu-Hong ChenJu-Wei Hsu
Oct 14, 2016·Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova·O K SavushkinaG Sh Burbaeva
May 21, 2017·Scientific Reports·Youngwoo Bryan YoonJun Soo Kwon
Oct 17, 2018·NPJ Schizophrenia·Richard NewtonBenedicto Crespo-Facorro
Apr 19, 2020·Brain Imaging and Behavior·Chuanjun ZhuoXueqin Song
Dec 18, 2020·Frontiers in Psychiatry·Roscoe O BradyKathryn E Lewandowski

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antipsychotic Drugs

Antipsychotic drugs are a class of medication primarily used to manage psychosis (including delusions, hallucinations, paranoia or disordered thought), principally in schizophrenia and bipolar disorder. Discover the latest research on antipsychotic drugs here

Ataxias

Ataxia is a neurological condition characterized by lack of voluntary coordination of muscle movements including loss of coordination, balance, and speech. Discover the latest research on different types of ataxias here.

Ataxia telangiectasia (MDS)

Ataxia telangiectasia is a rare neurodegenerative diseases caused by defects in the ATM gene, which is involved in DNA damage recognition and repair pathways. Here is the latest research on this autosomal recessive disease.

© 2021 Meta ULC. All rights reserved